Prana Company Profile

19:59 EDT 20th September 2014 | BioPortfolio



3275 Corporate View
United States of America


Phone: 760.566.1070
Fax: 760.566.1071

News Articles [42 Associated News Articles listed on BioPortfolio]

Prana falls after PBT2 misses in AD trial

Prana Biotechnology Ltd. (ASX:PBT; NASDAQ:PRAN) fell on NASDAQ on Monday after the company reported that PBT2 missed the primary endpoint of reducing beta amyloid plaque levels at one year vs. placebo...

Prana Alzheimer’s Drug Misses Primary Endpoint in Phase 2

Prana Biotechnology released the top-line results of the 12-month Phase 2 imaging trial in Alzheimer’s disease (IMAGINE Trial), based on draft results. Prana’s PBT2 did not meet its pri

Prana Updates Alzheimer's Development Program

Prana Biotechnology updated its clinical development program for Alzheimer's disease. Prof.

Ahead of the Bell: Prana Biotechnology shares skid

Shares of Prana Biotechnology Ltd. shed most of their value Monday before markets opened and after the Australian drug developer said its most advanced potential treatment missed the main goal in a st...

Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure

By Long Term Bio:Recently Prana Biotechnology (PRAN) had announced that its phase 2 trial testing patients with Alzheimer's disease had failed. Prana fell as much as 76% to a low of $2.51 per share in...

Australia’s Prana Misses Primary Endpoint In POC Alzheimer’s Disease Trial; Stock Tanks

Prana’s lead Alzheimer’s candidate fails both primary and secondary endpoints in Alzheimer’s proof-of-concept- trial, but the company still has hopes that an extension study will show a stronger...

PrAna Removes 4.5M Plastic Bags From Its Products, Cutting Waste, Not Quality

33 Percent of prAna’s Clothing and Accessories Now Arrives without Poly Packaging Carlsbad, CA (PRWEB) September 03, 2014 Seeing a way to make a positive change in the way it ships its products, pr...

Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals

NEW YORK, July 14, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Aeri Pharmaceuticals, Inc. (NASDAQ: AERI), DaVita HealthCare Partners Inc. (NYSE: DVA), Prana ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

Prana Biotechnology Limited

Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease ...



More Information about "Prana" on BioPortfolio

We have published hundreds of Prana news stories on BioPortfolio along with dozens of Prana Clinical Trials and PubMed Articles about Prana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Companies in our database. You can also find out about relevant Prana Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record